Assessment of Molecular Tools in Pediatric, Adolescent and Young Adult Meningioma Highlights the Need for Lifespan Precision in Neuro-Oncology
Journal of Neurological Surgery Part B: Skull Base · 01.03.2026 · 87 (S 01 S 01) · S1-S548
DOI: 10.1055/s-0046-1818906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.03.2026. Verfasst von Leo S. Yefet und 32 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Adolescent and young adult (AYA) patients remain underrepresented in neuro-oncology research. Despite being the second most common primary brain tumor in this population, meningiomas have not been studied using age-specific molecular analyses. DNA methylation–based classification and prognostic tools have transformed meningioma care. This study aimed to evaluate the performance of these tools across age groups.
Methods
We analyzed 1,568 meningiomas with DNA methylation and clinical data, including 18 pediatric patients ( 39 years). Pediatric and AYA (P/AYA) tumors were combined and compared with adult tumors. The performance of established molecular classifiers and recurrence predictors, as well as differences in chromosomal copy number alterations were compared across age groups.
Results
While histologic grading was comparable between cohorts, P/AYA tumors displayed significantly fewer aggressive molecular groups and lower frequencies of chromosomal arm losses, including 1p, 6q, and 14q. The adult-trained recurrence predictor failed in the P/AYA population (AUC 0.57), despite similar score distributions. Retraining the model on an age-specific cohort using an identical analytic framework improved performance (AUC 0.79) and enabled effective stratification of progression-free survival ( p = 0.00054). Importantly, 1p loss retained prognostic significance within the P/AYA group, supporting its clinical utility.
Conclusion
Molecular tools developed in adult-dominant cohorts do not generalize to younger patients due to both biological divergence and exclusion from model development. These findings underscore the need for age-specific molecular frameworks and highlight the imperative of including P/AYA populations in precision neuro-oncology research to ensure lifespan-equitable care. Publication History Article published online: 27 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Yefet, L. S., Landry, A., Wang, J., Liu, J., Patil, V., Gui, C., Ajisebutu, A., Ellenbogen, Y., Mamatjan, Y., Yakubov, R., Kaloti, R., Persaud, P., Wei, Q., Singh, O., Mansouri, S., Bunda, S., Cohen-Gadol, A. A., Tabatabai, G., Tatagiba, M., …, & Zadeh, G. (2026). Assessment of Molecular Tools in Pediatric, Adolescent and Young Adult Meningioma Highlights the Need for Lifespan Precision in Neuro-Oncology. Journal of Neurological Surgery Part B: Skull Base, 87(S 01 S 01), S1-S548. https://doi.org/10.1055/s-0046-1818906
Vancouver
Yefet LS, Landry A, Wang J, Liu J, Patil V, Gui C, et al. Assessment of Molecular Tools in Pediatric, Adolescent and Young Adult Meningioma Highlights the Need for Lifespan Precision in Neuro-Oncology. Journal of Neurological Surgery Part B: Skull Base. 2026;87(S 01 S 01):S1-S548. doi:10.1055/s-0046-1818906
BibTeX
@article{Yefet2026,
author = {Yefet, Leo S. and Landry, Alex and Wang, Justin and Liu, Jeff and Patil, Vikas and Gui, Chloe and Ajisebutu, Andrew and Ellenbogen, Yosef and Mamatjan, Yasin and Yakubov, Rebecca and Kaloti, Ramneet and Persaud, Phooja and Wei, Qingxia and Singh, Olivia and Mansouri, Sheila and Bunda, Severa and Cohen-Gadol, Aaron A. and Tabatabai, Ghazaleh and Tatagiba, Marcos and Behling, Felix and Barnholtz-Sloan, Jill S. and Sloan, Andrew E. and Chotai, Silky and Chambless, Lola B. and Mansouri, Alireza and Agnihotri, Sameer and Makarenko, Serge and Yip, Stephen and Tsang, Derek S. and Aldape, Kenneth and Gao, Andrew and Nassiri, Farshad and Zadeh, Gelareh},
title = {Assessment of Molecular Tools in Pediatric, Adolescent and Young Adult Meningioma Highlights the Need for Lifespan Precision in Neuro-Oncology},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2026},
volume = {87},
number = {S 01 S 01},
pages = {S1--S548},
doi = {10.1055/s-0046-1818906}
}
EUVIMED